Axis HT

product on market Tablet or Pill BSN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium and zinc are supported by strong evidence for maintaining hormonal balance and muscle function. The inclusion of StAR-P2 has limited research coverage regarding its specific efficacy. Overall, the profile focuses on essential minerals with a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Axis HT
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

150 mg (38% DV)
Within RDA (0.4× RDA) 316 studies (A:8, B:159)
10 mg (67% DV)
Within RDA (0.9× RDA) 263 studies (A:6, B:134)
StAR-P2
2238 mg

Other Ingredients

Microcrystalline Cellulose Stearic Acid Povidone Hydroxypropyl Methyl Cellulose Polyethyene Glycol
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Important: Use Axis-HT for at least 6 weeks in order to fully maximize its anabolic-androgenic potential. Do not exceed 12 weeks of coninuous use.

NOTE: If a reduction in androgenic effects is desired, cut dosage in half.

RECOMMENDED USE: As a dietary supplement, take 2 tablets 3 times per day, everyday. Take the first dose in the morning with breakfast, the second with lunch, and the third at night with your last meal. Axis-HT works synergistically with protein and carbohydrates to help promote muscle anabolism. It is therefore highly recommended that you take Axis-HT with a protein and carbohydrate-rich meal or shake. Stack Axis-HT with NO-Xplode, CellMass, and Nitrix.

Warnings & Precautions

Keep out of reach of children.

Do not use if you are pregnant or nursing.

After 12 weeks of use discontinue for at least 4 weeks.

Not intended for use by persons under the age of 18.

Reduce or dicontinue use if excessive sleeplessness, tremors, dizziness, nervousness, headaches, or heart palpitations occur. For use by healthy adults only.

WARNING: Seek advice from a health care practitioner prior to use if you have any pre-existing medical condition including, but not limited to: hypertension, hypotension, heart, liver, or thryoid disease, prostate hypertrophy, diabetes, psychological disorders, asthma, pernicious anemia, anxiety, depression, seizure disorder, cardiac arrhythmia, stroke, difficulty urinating due to prostate enlargement, or if you are taking an MAO inhibitor or any other prescription drug.

Additional Information

A Designer Anabolic & Androgenic Potentiator*

Pro-Testosterone Amplifier

SIZE* - STRENGTH* - HARDNESS* - LIBIDO*

V.1.305.0705US

Metadata

Product Details

UPC / SKU8 34266 00305 1
DSLD Entry Date2011-11-25
Product TypeOther Combinations
FormTablet or Pill
BrandBSN
DSLD ID2296
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.